Cart
sales@molnova.com
Diflucortolone valerate
CAS No. 59198-70-8
Diflucortolone valerate( Afusona | Diflucortolone 21-valerate )
Catalog No. M19819 CAS No. 59198-70-8
Diflucortolone valerate is a corticosteroid esterified with valeric acid. It helps to reduce itching redness and swelling.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 35 | In Stock |
|
| 5MG | 33 | In Stock |
|
| 10MG | 56 | In Stock |
|
| 25MG | 122 | In Stock |
|
| 50MG | 179 | In Stock |
|
| 100MG | 267 | In Stock |
|
| 200MG | 393 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDiflucortolone valerate
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiflucortolone valerate is a corticosteroid esterified with valeric acid. It helps to reduce itching redness and swelling.
-
DescriptionDiflucortolone valerate is a corticosteroid esterified with valeric acid. It helps to reduce itching redness and swelling.(In Vitro):Diflucortolone valerate is a potent corticosteroid esterified with valeric acid. Diflucortolone valerate helps reduce swelling, itching, and redness.(In Vivo):DL50 values are virtually non-toxic after single oral administration (mouse greater than 4 g/kg, rat ca. 3.1 g/kg, dog greater than 1 g/kg). Given s.c. (LD50 mouse ca. 180 mg/kg, rat ca. 13 mg/kg) and i.p. (LD50 mouse ca. 450 mg/kg, rat ca. 98 mg/kg) it is highly active and therefore produces also toxic effects.
-
In Vitro——
-
In Vivo——
-
SynonymsAfusona | Diflucortolone 21-valerate
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number59198-70-8
-
Formula Weight478.57
-
Molecular FormulaC27H36F2O5
-
Purity>98% (HPLC)
-
SolubilityDMSO: 80 mg/mL
-
SMILESCCCCC(=O)OCC(=O)[C@H]1[C@H](C)C[C@H]2[C@@H]3C[C@H](F)C4=CC(=O)C=C[C@]4(C)[C@@]3(F)[C@@H](O)C[C@]12C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
Cajanin
Cajanin has potential hypolipidemic effects,possibly via up-regulating the ABCA1 protein expression,subsequently resulting in increased macrophage cholesterol efflux and RCT, it can significantly improve basal glucose uptake in HepG2 cells, its improving effect is concentration dependent, it exhibits effects stronger than that of rosiglitazone, which has been used as an antidiabetic drug.
-
Corticotropin-releas...
Corticotropin-releasing factor human (Human CRF; Human corticotropin-releasing factor) is an immunomodulatory neuropeptide that acts to release ACTH from the anterior pituitary and stimulates the sympathetic nervous system and adrenal medulla. Functions by reducing hyperpolarizations. Acts as a functional antagonist of inflammatory mediators.
-
Calcium dobesilate
Calcium dobesilate(CaD) has angioprotective properties and protects endothelial cells partly by ameliorating HG?induced inflammation.
